The Economic Burden of Obesity by Glycemic Stage in the United States

被引:0
作者
Qian Li
Steven W. Blume
Joanna C. Huang
Mette Hammer
Thomas R. Graf
机构
[1] Evidera,Retrospective Observational Studies
[2] Novo Nordisk Inc,Health Economics and Outcomes Research
[3] Geisinger Health System,Population Health
来源
PharmacoEconomics | 2015年 / 33卷
关键词
Body Mass Index; Normal Body Mass Index; Body Mass Index Category; Pharmacy Cost; Healthcare Resource Utilization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:735 / 748
页数:13
相关论文
共 81 条
  • [11] Cawley J(1999)Predictive margins with survey data Biometrics. 12 50-170
  • [12] Meyerhoefer C(2011)Direct medical cost of overweight and obesity in the USA: a quantitative systematic review Obes Rev. 56 161-285
  • [13] Biener A(2014)Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace J Occup Environ Med. 28 277-1186
  • [14] Hammer M(2014)The association between employee obesity and employer costs: evidence from a panel of U.S. employers Am J Health Promot. 22 1179-997
  • [15] Wintfeld N(2014)Is overweight and class I obesity associated with increased health claims costs? Obesity. 50 991-504
  • [16] Wang Y(2008)Economic costs of obesity to self-insured employers J Occup Environ Med. 118 496-403
  • [17] Beydoun MA(2010)Excess health care costs of obesity in adults with diabetes mellitus: a claims data analysis Exp Clin Endocrinol Diabetes. 346 393-472
  • [18] Liang L(2002)Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med. 158 466-1124
  • [19] Caballero B(1998)Obesity, health services use, and health care costs among members of a health maintenance organization Arch Intern Med. 22 1116-529
  • [20] Kumanyika SK(1999)Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis Diabetes Care. 27 519-314